Patients with atopic dermatitis who had not received biologics prior to treatment with Opzelura were able to avoid biologics ...
Patients with atopic dermatitis who had not received biologics prior to treatment with Opzelura were able to avoid biologics ...
Clinical trial results found that a majority of patients with atopic dermatitis who were treated with Ebgylss achieved ...
Eli Lilly (NYSE:LLY) saw a notable 10% increase in its stock price over the last month, driven by several important events.
Eli Lilly (LLY) stock in focus as eczema therapy Ebglyss lead to complete skin clearance in 50% of subjects in a long-term ...
Tampa General Hospital (TGH) has again been named the top hospital in Tampa Bay and one of the top 100 hospitals in the United States, according to Newsweek's "World's Best Hospitals 2025" rankings.
Feetures, America's #1 running sock, is dedicated to supporting athletes of all ages and promoting the importance of being ...
New results show Eli Lilly (LLY) and Company’s Ebglyss achieved deep and sustained response for patients with moderate-to-severe atopic ...
MicroStrategy’s Andrew Kang talks about bitcoin holdings, Krispy Kreme’s Jeremiah Ashukian discusses business model changes ...
After scoring a long-awaited FDA approval last fall, Eli Lilly has launched a consumer-facing campaign to get the word out ...
Spanish pharmaceutical company Almirall expects to almost double its annual revenue by 2030, boosted by higher sales of its dermatological products in Europe, CEO Carlos Gallardo said on Wednesday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results